|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 95 No. 2 (January 15), 2000:
pp. 535-542
CD38 ligation inhibits normal and leukemic myelopoiesis
Elisabetta Todisco,
Toshio Suzuki,
Kleebsabai Srivannaboon,
Elaine Coustan-Smith,
Susana C. Raimondi,
Frederick G. Behm,
Akira Kitanaka, and
Dario Campana
From the Departments of Hematology-Oncology and Pathology, St. Jude
Children's Research Hospital, and University of Tennessee
College of Medicine, Memphis, TN; and First Department of Internal
Medicine, Kagawa Medical University, Japan.
CD38 is a transmembrane molecule whose expression varies during
hematopoietic cell differentiation. We used stroma-supported cultures
of human myeloid cells to assess the effects of CD38 ligation on
myeloid differentiation. In 8 experiments with CD34+
cells purified from normal bone marrow or cord blood, flow
cytometry used with antibodies to CD34 and myeloperoxidase (MPO)
identified 4 cell populations after 7 days of culture. Addition of
anti-CD38 (T16) to the cultures induced a profound reduction of the
most mature (CD34 MPO++) cell population,
which includes promyelocytes, myelocytes and metamyelocytes; mean (± SD) cell recovery was 12.8% ± 9.8% of that in parallel cultures
with an isotype-matched control antibody. The suppressive effect of
CD38 ligation on phenotypically more immature normal cells was
inconsistent but generally less pronounced. Recovery of
CD34++MPO cells was 63.3% ± 24.4%, recovery of CD34[+/]
MPO cells was 95.3% ± 35.1%, and recovery of CD34MPO+
cells was 42.0% ± 18.7% of that in control cultures. However, anti-CD38 suppressed recovery of cells obtained from 6 patients with
CD38+ acute myeloid leukemia; after 7-day cultures, cell
recovery was 25.2% ± 21.7% of that in control cultures. Cell
recovery was also reduced by F(ab')2 or Fab fragments
of anti-CD38. CD38 ligation dramatically suppressed recovery of murine
32D myeloid cells transfected with human CD38 and cocultured with
stroma (3.8% ± 7.3%; n = 7). CD38 ligation of
CD38 + 32D cells also induced cell aggregation,
tyrosine kinase activity, and Ca++ influx. We
conclude that CD38 mediates signals that culminate in suppression
of myeloid cell growth and survival.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
F. Malavasi, S. Deaglio, A. Funaro, E. Ferrero, A. L. Horenstein, E. Ortolan, T. Vaisitti, and S. Aydin
Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology
Physiol Rev,
July 1, 2008;
88(3):
841 - 886.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Gallay, L. Anani, A. Lopez, P. Colombat, C. Binet, J. Domenech, B. B. Weksler, F. Malavasi, and O. Herault
The Role of Platelet/Endothelial Cell Adhesion Molecule 1 (CD31) and CD38 Antigens in Marrow Microenvironmental Retention of Acute Myelogenous Leukemia Cells
Cancer Res.,
September 15, 2007;
67(18):
8624 - 8632.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Marchetti, A. Antonelli, R. Lupi, L. Marselli, P. Fallahi, C. Nesti, G. Baj, and E. Ferrannini
Prolonged In Vitro Exposure to Autoantibodies Against CD38 Impairs the Function and Survival of Human Pancreatic Islets
Diabetes,
December 1, 2002;
51(90003):
S474 - 477.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Srivannaboon, A. B. Shanafelt, E. Todisco, C. P. Forte, F. G. Behm, S. C. Raimondi, C.-H. Pui, and D. Campana
Interleukin-4 variant (BAY 36-1677) selectively induces apoptosis in acute lymphoblastic leukemia cells
Blood,
February 1, 2001;
97(3):
752 - 758.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
